GSK enters agreement to obtain exclusive license for hepatitis B therapy to expand bepirovirsen development Ruchika Sharma1 Nov 2023 11:30 AM ISTGSK will be responsible for upfront and potential milestone-based payments to both Janssen and Arrowhead totalling approximately USD 1 billion.
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 4:21 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
GSK, Hansoh Pharma ink pact for HS-20089 Ruchika Sharma24 Oct 2023 3:30 PM ISTUnder the terms of this agreement, GSK will pay an USD 85 million upfront payment.
GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer Ruchika Sharma19 Oct 2023 2:41 PM ISTUK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
Another California lawsuit on heartburn drug Zantac settled by GSK Ruchika Sharma11 Oct 2023 4:30 PM ISTThe FDA in 2020 pulled all brand name Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.
GSK, Zhifei to co-promote shingles vaccine Shingrix in China Ruchika Sharma10 Oct 2023 12:30 PM ISTSubject to the terms of the agreement, Zhifei will purchase agreed volumes of Shingrix with a value to GSK of £2.5 billion in total over the initial...
British drugmaker GSK raises USD 1.1 billion from Haleon stake sale Ruchika Sharma7 Oct 2023 1:30 PM ISTPfizer, which holds a 32% stake in Haleon, said in May it plans to cut its ownership in a "slow and methodical" manner within months.
Wendy Becker to join GSK board as Non-Executive Director Ruchika Sharma28 Sept 2023 1:30 PM ISTLondon: GSK plc has announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with effect from 1 October 2023.On...
Scynexis to recall GSK partnered antifungal pill over cross contamination risk Ruchika Sharma26 Sept 2023 4:30 PM ISTScynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a...
GSK HIV prevention drug gets European Commission authorisation Ruchika Sharma19 Sept 2023 2:30 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,...
GSK gets USFDA nod for bone marrow cancer therapy Ojjaara Ruchika Sharma16 Sept 2023 11:54 AM ISTOjjaara is a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor.
